Rheumatoid arthritis therapy (Apollo Life Sciences)

N/A

Report date: 2022/01/24 13:25:19

Base Information

Drug NameRheumatoid arthritis therapy (Apollo Life Sciences)
Drug Alias NameOral TNF blocker for rheumatoid arthritis - Apollo Life SciencesALS-00T2 oral - Apollo Life Sciences
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionTumor necrosis factor receptor inhibitors
TargetsTumor necrosis factor receptor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApollo Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApollo Life Sciences
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A